Highlights

array(40) {
  [0]=>
  string(4) "8521"
  ["article_id"]=>
  string(4) "8521"
  [1]=>
  string(64) "Workers at Risk for COVID-19 Exposure Can Access Online Training"
  ["article_title"]=>
  string(64) "Workers at Risk for COVID-19 Exposure Can Access Online Training"
  [2]=>
  string(150) "THURSDAY, March 26, 2020 -- The National Institutes of Health has launched a new website with educational resources for hospital employees, emergency "
  ["short_description"]=>
  string(150) "THURSDAY, March 26, 2020 -- The National Institutes of Health has launched a new website with educational resources for hospital employees, emergency "
  [3]=>
  string(253) "THURSDAY, March 26, 2020 -- The National Institutes of Health has launched a new website with educational resources for hospital employees, emergency first responders, and other workers at risk for exposure to COVID-19.&#nlThe COVID-19 virtual safety..."
  ["description"]=>
  string(253) "THURSDAY, March 26, 2020 -- The National Institutes of Health has launched a new website with educational resources for hospital employees, emergency first responders, and other workers at risk for exposure to COVID-19.&#nlThe COVID-19 virtual safety..."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(1) "6"
  ["rss_id"]=>
  string(1) "6"
  [14]=>
  string(203) "https://www.drugs.com/news/workers-risk-covid-19-exposure-can-access-online-training-89224.html?utm_source=ddc&utm_medium=rss&utm_campaign=Workers+at+Risk+for+COVID-19+Exposure+Can+Access+Online+Training"
  ["blog_url"]=>
  string(203) "https://www.drugs.com/news/workers-risk-covid-19-exposure-can-access-online-training-89224.html?utm_source=ddc&utm_medium=rss&utm_campaign=Workers+at+Risk+for+COVID-19+Exposure+Can+Access+Online+Training"
  [15]=>
  string(19) "2020-03-27 03:03:21"
  ["add_date"]=>
  string(19) "2020-03-27 03:03:21"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2020-03-31 11:17:59"
  ["create_at"]=>
  string(19) "2020-03-31 11:17:59"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

Workers at Risk for COVID-19 Exposure Can Access Online Training

THURSDAY, March 26, 2020 -- The National Institutes of Health has launched a new website with educational resources for

array(40) {
  [0]=>
  string(4) "8628"
  ["article_id"]=>
  string(4) "8628"
  [1]=>
  string(51) "Legal marijuana products too strong for pain relief"
  ["article_title"]=>
  string(51) "Legal marijuana products too strong for pain relief"
  [2]=>
  string(150) "More than 90% of the legal marijuana products offered in medical dispensaries are much stronger than what clinical studies have shown that doctors rec"
  ["short_description"]=>
  string(150) "More than 90% of the legal marijuana products offered in medical dispensaries are much stronger than what clinical studies have shown that doctors rec"
  [3]=>
  string(208) "More than 90% of the legal marijuana products offered in medical dispensaries are much stronger than what clinical studies have shown that doctors recommend for chronic pain relief, according to a new study. "
  ["description"]=>
  string(208) "More than 90% of the legal marijuana products offered in medical dispensaries are much stronger than what clinical studies have shown that doctors recommend for chronic pain relief, according to a new study. "
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "29"
  ["rss_id"]=>
  string(2) "29"
  [14]=>
  string(62) "https://www.sciencedaily.com/releases/2020/03/200326144354.htm"
  ["blog_url"]=>
  string(62) "https://www.sciencedaily.com/releases/2020/03/200326144354.htm"
  [15]=>
  string(19) "2020-03-27 02:43:54"
  ["add_date"]=>
  string(19) "2020-03-27 02:43:54"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2020-03-31 11:23:27"
  ["create_at"]=>
  string(19) "2020-03-31 11:23:27"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

Legal marijuana products too strong for pain relief

More than 90% of the legal marijuana products offered in medical dispensaries are much stronger than what clinical studi

array(40) {
  [0]=>
  string(4) "8749"
  ["article_id"]=>
  string(4) "8749"
  [1]=>
  string(86) "Gates Foundation in ‘unprecedented’ coronavirus partnership with industry"
  ["article_title"]=>
  string(86) "Gates Foundation in ‘unprecedented’ coronavirus partnership with industry"
  [2]=>
  string(141) "âCollective action is critical,â says Novartis CEO on industry partnership with Gates Foundation to accelerate treatments for COVID-19."
  ["short_description"]=>
  string(141) "âCollective action is critical,â says Novartis CEO on industry partnership with Gates Foundation to accelerate treatments for COVID-19."
  [3]=>
  string(141) "âCollective action is critical,â says Novartis CEO on industry partnership with Gates Foundation to accelerate treatments for COVID-19."
  ["description"]=>
  string(141) "âCollective action is critical,â says Novartis CEO on industry partnership with Gates Foundation to accelerate treatments for COVID-19."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(3) "107"
  ["rss_id"]=>
  string(3) "107"
  [14]=>
  string(160) "https://www.biopharma-reporter.com/Article/2020/03/26/Gates-Foundation-partners-with-industry-on-coronavirus?utm_source=RSS_Feed&utm_medium=RSS&utm_campaign=RSS"
  ["blog_url"]=>
  string(160) "https://www.biopharma-reporter.com/Article/2020/03/26/Gates-Foundation-partners-with-industry-on-coronavirus?utm_source=RSS_Feed&utm_medium=RSS&utm_campaign=RSS"
  [15]=>
  string(19) "2020-03-27 01:16:00"
  ["add_date"]=>
  string(19) "2020-03-27 01:16:00"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2020-03-31 11:24:19"
  ["create_at"]=>
  string(19) "2020-03-31 11:24:19"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

Gates Foundation in ‘unprecedented’ coronavirus partnership with industry

âCollective action is critical,â says Novartis CEO on industry partnership with Gates Foundation to accelerate tre

array(40) {
  [0]=>
  string(4) "8750"
  ["article_id"]=>
  string(4) "8750"
  [1]=>
  string(63) "Astellas and CytomX team up to target solid tumors with T-cells"
  ["article_title"]=>
  string(63) "Astellas and CytomX team up to target solid tumors with T-cells"
  [2]=>
  string(86) "The two partners will work to develop clinical candidates for the treatment of cancer."
  ["short_description"]=>
  string(86) "The two partners will work to develop clinical candidates for the treatment of cancer."
  [3]=>
  string(86) "The two partners will work to develop clinical candidates for the treatment of cancer."
  ["description"]=>
  string(86) "The two partners will work to develop clinical candidates for the treatment of cancer."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(3) "107"
  ["rss_id"]=>
  string(3) "107"
  [14]=>
  string(135) "https://www.biopharma-reporter.com/Article/2020/03/26/Astellas-partners-with-CytomX?utm_source=RSS_Feed&utm_medium=RSS&utm_campaign=RSS"
  ["blog_url"]=>
  string(135) "https://www.biopharma-reporter.com/Article/2020/03/26/Astellas-partners-with-CytomX?utm_source=RSS_Feed&utm_medium=RSS&utm_campaign=RSS"
  [15]=>
  string(19) "2020-03-27 01:12:00"
  ["add_date"]=>
  string(19) "2020-03-27 01:12:00"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2020-03-31 11:24:19"
  ["create_at"]=>
  string(19) "2020-03-31 11:24:19"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

Astellas and CytomX team up to target solid tumors with T-cells

The two partners will work to develop clinical candidates for the treatment of cancer.

array(40) {
  [0]=>
  string(4) "8719"
  ["article_id"]=>
  string(4) "8719"
  [1]=>
  string(63) "TriNetX adapts platform to answer coronavirus recruitment needs"
  ["article_title"]=>
  string(63) "TriNetX adapts platform to answer coronavirus recruitment needs"
  [2]=>
  string(150) "TriNetX adapts its data platform to reflect the rising needs of the clinical research industry that works to fight the spread of the coronavirus pande"
  ["short_description"]=>
  string(150) "TriNetX adapts its data platform to reflect the rising needs of the clinical research industry that works to fight the spread of the coronavirus pande"
  [3]=>
  string(177) "TriNetX adapts its data platform to reflect the rising needs of the clinical research industry that works to fight the spread of the coronavirus pandemic with drug developments."
  ["description"]=>
  string(177) "TriNetX adapts its data platform to reflect the rising needs of the clinical research industry that works to fight the spread of the coronavirus pandemic with drug developments."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "49"
  ["rss_id"]=>
  string(2) "49"
  [14]=>
  string(166) "https://www.outsourcing-pharma.com/Article/2020/03/26/TriNetX-adapts-platform-to-answer-coronavirus-research-needs?utm_source=RSS_Feed&utm_medium=RSS&utm_campaign=RSS"
  ["blog_url"]=>
  string(166) "https://www.outsourcing-pharma.com/Article/2020/03/26/TriNetX-adapts-platform-to-answer-coronavirus-research-needs?utm_source=RSS_Feed&utm_medium=RSS&utm_campaign=RSS"
  [15]=>
  string(19) "2020-03-27 00:54:00"
  ["add_date"]=>
  string(19) "2020-03-27 00:54:00"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2020-03-31 11:23:44"
  ["create_at"]=>
  string(19) "2020-03-31 11:23:44"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

TriNetX adapts platform to answer coronavirus recruitment needs

TriNetX adapts its data platform to reflect the rising needs of the clinical research industry that works to fight the s

array(40) {
  [0]=>
  string(4) "8629"
  ["article_id"]=>
  string(4) "8629"
  [1]=>
  string(54) "How cognitive intelligence is a whole brain phenomenon"
  ["article_title"]=>
  string(54) "How cognitive intelligence is a whole brain phenomenon"
  [2]=>
  string(143) "An international collaborative study provides findings on the neural basis of intelligence, otherwise known as general cognitive ability (IQ). "
  ["short_description"]=>
  string(143) "An international collaborative study provides findings on the neural basis of intelligence, otherwise known as general cognitive ability (IQ). "
  [3]=>
  string(143) "An international collaborative study provides findings on the neural basis of intelligence, otherwise known as general cognitive ability (IQ). "
  ["description"]=>
  string(143) "An international collaborative study provides findings on the neural basis of intelligence, otherwise known as general cognitive ability (IQ). "
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "29"
  ["rss_id"]=>
  string(2) "29"
  [14]=>
  string(62) "https://www.sciencedaily.com/releases/2020/03/200326124145.htm"
  ["blog_url"]=>
  string(62) "https://www.sciencedaily.com/releases/2020/03/200326124145.htm"
  [15]=>
  string(19) "2020-03-27 00:41:45"
  ["add_date"]=>
  string(19) "2020-03-27 00:41:45"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2020-03-31 11:23:27"
  ["create_at"]=>
  string(19) "2020-03-31 11:23:27"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

How cognitive intelligence is a whole brain phenomenon

An international collaborative study provides findings on the neural basis of intelligence, otherwise known as general c

array(40) {
  [0]=>
  string(4) "8679"
  ["article_id"]=>
  string(4) "8679"
  [1]=>
  string(48) "Thermo Fisher Granted CE Mark for COVID-19 Test "
  ["article_title"]=>
  string(48) "Thermo Fisher Granted CE Mark for COVID-19 Test "
  [2]=>
  string(153) "&#nlThermo Fisher Scientific is bringing its diagnostic detects nucleic acid from SARS-CoV-2, the virus that causes COVID-19, to Europe. The Waltham, MA-"
  ["short_description"]=>
  string(153) "&#nlThermo Fisher Scientific is bringing its diagnostic detects nucleic acid from SARS-CoV-2, the virus that causes COVID-19, to Europe. The Waltham, MA-"
  [3]=>
  string(2388) "&#nl

Thermo Fisher Scientific is bringing its diagnostic detects nucleic acid from SARS-CoV-2, the virus that causes COVID-19, to Europe. The Waltham, MA-based company said earlier today it had received CE mark for the test.

&#nl

The test uses Applied Biosystems TaqPath Assay technology and is designed to provide patient results within four hours of a sample being received by a lab. The estimated time-to-result also includes time for sample preparation and instrument analysis.

&#nl

"The CE mark certification is an important step in combatting the outbreak of COVID-19 across Europe," said Marc Casper, chairman, president and CEO of Thermo Fisher Scientific. "We are committed to fighting this disease and we will continue to work with regulatory authorities and customers around the world to expand the availability of diagnostic testing and stem the spread of the coronavirus."

&#nl

Europe has become the epicenter for the COVID-19 the World Health Organization said. Italy’s death toll from the virus has been the highest – hitting about 7,503 people, according to www.worldometers.com. The website shows Italy has more than 74,000 patients that have been diagnosed with coronavirus and 9, 362 recovering.

&#nl

However, Italy’s number of new cases has declined for the fourth day in a row according to a report from CNBC. Thermo Fisher’s CE mark designation comes only a few short days after FDA granted Thermo Fisher Scientific Emergency Use Authorization for the test. Thermo Fisher joins a growing number of companies that have either received approval or EUA for tests this month.

&#nl

Currently, the firm is in the middle of acquiring Qiagen for about $11.5 billion. Thermo Fisher said the acquisition would help it boost its molecular diagnostics offerings.

&#nl

 

" ["description"]=> string(2388) "&#nl

Thermo Fisher Scientific is bringing its diagnostic detects nucleic acid from SARS-CoV-2, the virus that causes COVID-19, to Europe. The Waltham, MA-based company said earlier today it had received CE mark for the test.

&#nl

The test uses Applied Biosystems TaqPath Assay technology and is designed to provide patient results within four hours of a sample being received by a lab. The estimated time-to-result also includes time for sample preparation and instrument analysis.

&#nl

"The CE mark certification is an important step in combatting the outbreak of COVID-19 across Europe," said Marc Casper, chairman, president and CEO of Thermo Fisher Scientific. "We are committed to fighting this disease and we will continue to work with regulatory authorities and customers around the world to expand the availability of diagnostic testing and stem the spread of the coronavirus."

&#nl

Europe has become the epicenter for the COVID-19 the World Health Organization said. Italy’s death toll from the virus has been the highest – hitting about 7,503 people, according to www.worldometers.com. The website shows Italy has more than 74,000 patients that have been diagnosed with coronavirus and 9, 362 recovering.

&#nl

However, Italy’s number of new cases has declined for the fourth day in a row according to a report from CNBC. Thermo Fisher’s CE mark designation comes only a few short days after FDA granted Thermo Fisher Scientific Emergency Use Authorization for the test. Thermo Fisher joins a growing number of companies that have either received approval or EUA for tests this month.

&#nl

Currently, the firm is in the middle of acquiring Qiagen for about $11.5 billion. Thermo Fisher said the acquisition would help it boost its molecular diagnostics offerings.

&#nl

 

" [4]=> NULL ["image"]=> NULL [5]=> NULL ["big_image"]=> NULL [6]=> NULL ["feature_images"]=> NULL [7]=> NULL ["employer_id"]=> NULL [8]=> string(1) "1" ["category"]=> string(1) "1" [9]=> string(3) "RSS" ["added_by"]=> string(3) "RSS" [10]=> string(2) "10" ["status"]=> string(2) "10" [11]=> NULL ["highlight_status"]=> NULL [12]=> NULL ["hit_count"]=> NULL [13]=> string(2) "40" ["rss_id"]=> string(2) "40" [14]=> string(70) "https://www.mddionline.com/thermo-fisher-granted-ce-mark-covid-19-test" ["blog_url"]=> string(70) "https://www.mddionline.com/thermo-fisher-granted-ce-mark-covid-19-test" [15]=> string(19) "2020-03-27 00:19:55" ["add_date"]=> string(19) "2020-03-27 00:19:55" [16]=> NULL ["bythe"]=> NULL [17]=> NULL ["timestamp"]=> NULL [18]=> string(19) "2020-03-31 11:23:39" ["create_at"]=> string(19) "2020-03-31 11:23:39" [19]=> string(0) "" ["slug"]=> string(0) "" }

Thermo Fisher Granted CE Mark for COVID-19 Test

array(40) {
  [0]=>
  string(4) "8720"
  ["article_id"]=>
  string(4) "8720"
  [1]=>
  string(46) "MedPharm expands drug discovery lab facilities"
  ["article_title"]=>
  string(46) "MedPharm expands drug discovery lab facilities"
  [2]=>
  string(147) "The newly expanded facility in Research Triangle park features a range of larger and added laboratory spaces, including a dedicated innovation lab."
  ["short_description"]=>
  string(147) "The newly expanded facility in Research Triangle park features a range of larger and added laboratory spaces, including a dedicated innovation lab."
  [3]=>
  string(147) "The newly expanded facility in Research Triangle park features a range of larger and added laboratory spaces, including a dedicated innovation lab."
  ["description"]=>
  string(147) "The newly expanded facility in Research Triangle park features a range of larger and added laboratory spaces, including a dedicated innovation lab."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "49"
  ["rss_id"]=>
  string(2) "49"
  [14]=>
  string(154) "https://www.outsourcing-pharma.com/Article/2020/03/26/MedPharm-expands-its-Research-Triangle-Park-labs?utm_source=RSS_Feed&utm_medium=RSS&utm_campaign=RSS"
  ["blog_url"]=>
  string(154) "https://www.outsourcing-pharma.com/Article/2020/03/26/MedPharm-expands-its-Research-Triangle-Park-labs?utm_source=RSS_Feed&utm_medium=RSS&utm_campaign=RSS"
  [15]=>
  string(19) "2020-03-26 22:44:00"
  ["add_date"]=>
  string(19) "2020-03-26 22:44:00"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2020-03-31 11:23:44"
  ["create_at"]=>
  string(19) "2020-03-31 11:23:44"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

MedPharm expands drug discovery lab facilities

The newly expanded facility in Research Triangle park features a range of larger and added laboratory spaces, including

array(40) {
  [0]=>
  string(4) "8690"
  ["article_id"]=>
  string(4) "8690"
  [1]=>
  string(50) "UK Government orders 10,000 ventilators from Dyson"
  ["article_title"]=>
  string(50) "UK Government orders 10,000 ventilators from Dyson"
  [2]=>
  string(150) "The new CoVent ventilator designed by Dyson and TTP had outside experts from Medicines and Healthcare products Regulatory Agency (MHRA) and the NHS in"
  ["short_description"]=>
  string(150) "The new CoVent ventilator designed by Dyson and TTP had outside experts from Medicines and Healthcare products Regulatory Agency (MHRA) and the NHS in"
  [3]=>
  string(187) "The new CoVent ventilator designed by Dyson and TTP had outside experts from Medicines and Healthcare products Regulatory Agency (MHRA) and the NHS involved throughout the design process."
  ["description"]=>
  string(187) "The new CoVent ventilator designed by Dyson and TTP had outside experts from Medicines and Healthcare products Regulatory Agency (MHRA) and the NHS involved throughout the design process."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "41"
  ["rss_id"]=>
  string(2) "41"
  [14]=>
  string(92) "https://www.medicalplasticsnews.com/news/uk-government-orders-10-000-ventilators-from-dyson/"
  ["blog_url"]=>
  string(92) "https://www.medicalplasticsnews.com/news/uk-government-orders-10-000-ventilators-from-dyson/"
  [15]=>
  string(19) "2020-03-26 22:17:35"
  ["add_date"]=>
  string(19) "2020-03-26 22:17:35"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2020-03-31 11:23:40"
  ["create_at"]=>
  string(19) "2020-03-31 11:23:40"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

UK Government orders 10,000 ventilators from Dyson

The new CoVent ventilator designed by Dyson and TTP had outside experts from Medicines and Healthcare products Regulator

array(40) {
  [0]=>
  string(4) "8500"
  ["article_id"]=>
  string(4) "8500"
  [1]=>
  string(52) "Meth Use, Addiction on the Rise Among Americans: CDC"
  ["article_title"]=>
  string(52) "Meth Use, Addiction on the Rise Among Americans: CDC"
  [2]=>
  string(150) "THURSDAY, March 26, 2020 -- Methamphetamine use is soaring again, with nearly one million Americans hooked on it, according to federal health official"
  ["short_description"]=>
  string(150) "THURSDAY, March 26, 2020 -- Methamphetamine use is soaring again, with nearly one million Americans hooked on it, according to federal health official"
  [3]=>
  string(254) "THURSDAY, March 26, 2020 -- Methamphetamine use is soaring again, with nearly one million Americans hooked on it, according to federal health officials.&#nlBetween 2015 and 2018, about 53% of the 1.6 million meth users were addicted to it and slightly..."
  ["description"]=>
  string(254) "THURSDAY, March 26, 2020 -- Methamphetamine use is soaring again, with nearly one million Americans hooked on it, according to federal health officials.&#nlBetween 2015 and 2018, about 53% of the 1.6 million meth users were addicted to it and slightly..."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(1) "5"
  ["rss_id"]=>
  string(1) "5"
  [14]=>
  string(167) "https://www.drugs.com/news/meth-rise-among-americans-cdc-89220.html?utm_source=ddc&utm_medium=rss&utm_campaign=Meth+Use%2C+Addiction+on+the+Rise+Among+Americans%3A+CDC"
  ["blog_url"]=>
  string(167) "https://www.drugs.com/news/meth-rise-among-americans-cdc-89220.html?utm_source=ddc&utm_medium=rss&utm_campaign=Meth+Use%2C+Addiction+on+the+Rise+Among+Americans%3A+CDC"
  [15]=>
  string(19) "2020-03-26 22:03:35"
  ["add_date"]=>
  string(19) "2020-03-26 22:03:35"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2020-03-31 11:17:59"
  ["create_at"]=>
  string(19) "2020-03-31 11:17:59"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

Meth Use, Addiction on the Rise Among Americans: CDC

THURSDAY, March 26, 2020 -- Methamphetamine use is soaring again, with nearly one million Americans hooked on it, accord

array(40) {
  [0]=>
  string(4) "8668"
  ["article_id"]=>
  string(4) "8668"
  [1]=>
  string(66) "FDA Approves Bristol Myers MS Drug, But Pandemic Will Delay Launch"
  ["article_title"]=>
  string(66) "FDA Approves Bristol Myers MS Drug, But Pandemic Will Delay Launch"
  [2]=>
  string(155) "A multiple sclerosis drug that came to Bristol Myers Squibb via its acquisition of Celgene last year was approved Thursday but don’t expect it to re"
  ["short_description"]=>
  string(155) "A multiple sclerosis drug that came to Bristol Myers Squibb via its acquisition of Celgene last year was approved Thursday but don’t expect it to re"
  [3]=>
  string(347) "A multiple sclerosis drug that came to Bristol Myers Squibb via its acquisition of Celgene last year was approved Thursday but don’t expect it to reach patients any time soon. The company says the drug’s launch will be delayed due to the coronavirus pandemic. The Bristol (NYSE: BMY) drug, ozanimod (Zeposia), is one of the […]"
  ["description"]=>
  string(347) "A multiple sclerosis drug that came to Bristol Myers Squibb via its acquisition of Celgene last year was approved Thursday but don’t expect it to reach patients any time soon. The company says the drug’s launch will be delayed due to the coronavirus pandemic. The Bristol (NYSE: BMY) drug, ozanimod (Zeposia), is one of the […]"
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "36"
  ["rss_id"]=>
  string(2) "36"
  [14]=>
  string(106) "https://xconomy.com/new-york/2020/03/26/fda-approves-bristol-myers-ms-drug-but-pandemic-will-delay-launch/"
  ["blog_url"]=>
  string(106) "https://xconomy.com/new-york/2020/03/26/fda-approves-bristol-myers-ms-drug-but-pandemic-will-delay-launch/"
  [15]=>
  string(19) "2020-03-26 21:58:42"
  ["add_date"]=>
  string(19) "2020-03-26 21:58:42"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2020-03-31 11:23:33"
  ["create_at"]=>
  string(19) "2020-03-31 11:23:33"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

FDA Approves Bristol Myers MS Drug, But Pandemic Will Delay Launch

A multiple sclerosis drug that came to Bristol Myers Squibb via its acquisition of Celgene last year was approved Thursd

array(40) {
  [0]=>
  string(4) "8691"
  ["article_id"]=>
  string(4) "8691"
  [1]=>
  string(86) "Engineering group offers helping hand for UK manufacturers during coronavirus pandemic"
  ["article_title"]=>
  string(86) "Engineering group offers helping hand for UK manufacturers during coronavirus pandemic"
  [2]=>
  string(120) "Derbyshire engineering group, Carfulan Group, has announced its technology will be available for subcontracting work."
  ["short_description"]=>
  string(120) "Derbyshire engineering group, Carfulan Group, has announced its technology will be available for subcontracting work."
  [3]=>
  string(120) "Derbyshire engineering group, Carfulan Group, has announced its technology will be available for subcontracting work."
  ["description"]=>
  string(120) "Derbyshire engineering group, Carfulan Group, has announced its technology will be available for subcontracting work."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "41"
  ["rss_id"]=>
  string(2) "41"
  [14]=>
  string(102) "https://www.medicalplasticsnews.com/news/engineering-group-offers-helping-hand-for-uk-manufacturers-d/"
  ["blog_url"]=>
  string(102) "https://www.medicalplasticsnews.com/news/engineering-group-offers-helping-hand-for-uk-manufacturers-d/"
  [15]=>
  string(19) "2020-03-26 21:56:32"
  ["add_date"]=>
  string(19) "2020-03-26 21:56:32"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2020-03-31 11:23:40"
  ["create_at"]=>
  string(19) "2020-03-31 11:23:40"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

Engineering group offers helping hand for UK manufacturers during coronavirus pandemic

Derbyshire engineering group, Carfulan Group, has announced its technology will be available for subcontracting work.